24

ASTA Corporation

246720 · KQ · Healthcare / Medical Instruments & Supplies

6,070.00KRW+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close6,070.00
Open6,070.00
Day Range6,070.00 – 6,070.00
52-Week Range5,900.00 – 11,080.00
Volume0
Market Cap99.43B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.36
50-Day Avg6,070.00
200-Day Avg6,623.95

About

ASTA Corporation engages in the development of diagnosis solutions in South Korea. The company offers microorganism identification systems, such as MicroIDSys and MicroIDSys Elite, which is used for applications in the areas of rapid diagnosis of infectious diseases, food hygiene management, agriculture and stockbreeding quarantines, and prevention of bio-terrorism. It also provides IDSys LT/RT, a MALDI-TOF mass spectrometry solution; NosIDSys, an economical diagnostic system used for diagnosis and prevention of rare incurable diseases, such as cancer and degenerative brain diseases; LDI-TOF, an laser desorption ionization time of flight mass spectrometer for OLED analysis and test; MALDI Plate, a disposable plate; and rapid enzyme digestion system. In addition, the company provides diagnostics software. ASTA Corporation was founded in 2006 and is based in Suwon-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Eung-Joon Jo
  • Employees26
  • HeadquartersAICT Building A, Suwon-si, South Korea, 16229, Korea
  • Websitehttps://www.astams.com

Leadership

  • Mr. Eung-Joon JoCEO & Chairman · b. 1954
  • Ms. Yang-Sun KimChief Executive Officer and Director · b. 1958
  • Mr. Eung-Su ChoPresident and Head of Overall Business Management · b. 1955
  • Ms. Sook-Hwa KwonHead of Sales and Managing Director · b. 1967

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue3.35B3.13B3.35B2.59B
Growth (%)--6.34%+7.07%-22.65%
Cost of Revenue1.78B1.56B2.40B1.34B
Gross Profit1.56B1.58B957.86M1.26B
Gross Margin46.66%50.34%28.55%48.46%
Operating Expense4.34B4.30B4.98B3.85B
Operating Income-2.78B-2.72B-4.02B-2.59B
Operating Margin-83.07%-86.87%-119.79%-99.80%
EBITDA-1.85B-1.72B-2.91B-2.45B
EBITDA Margin-55.41%-55.03%-86.60%-94.23%
Net Income-2.80B-2.81B-3.86B-3.30B
Net Income Margin-83.68%-89.78%-115.18%-127.31%
R&D454.12M645.30M750.21M605.34M
R&D as % of Total Revenue13.57%20.60%22.36%23.33%
Interest Expense140.67M236.49M198.95M421.63M
Interest Expense % of Total Revenue4.20%7.55%5.93%16.25%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets10.94B9.71B8.56B15.49B
Total Liabilities3.70B3.54B4.41B6.27B
Total Equity7.24B6.17B4.15B9.22B
Cash3.17B1.38B21.32M2.91B
Net Debt--868.26M-

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.63B-4.03B-2.11B-3.35B
Capital Expenditure229.05M18.29M453.78M29.62M
Free Cash Flow-1.85B-4.05B-2.57B-3.38B
FCF to OCF114.09%100.45%121.46%100.88%

Earnings

Report DateMar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------
EPS Actual-164.89-163.53-188.9376.40-51.49-2.94-93.88-91.28-102.90-210.39-164.57-521.74-118.71-34.34-269.88-460.34-94.14-71.38-65.67-73.53-105.98-52.56-34.39-27.85-49.17-57.77-88.01-22.06-104.75-80.08-62.94-44.68-112.94-5.40-42.79-73.20-95.63-49.49
Surprise--------------------------------------
Timing--------------------------------------

Key Statistics & Ratios

Market Cap99.43B
Enterprise Value84.88B
Trailing P/E0.00
Forward P/E0.00
Price / Sales29.35
Price / Book5.47
Revenue (TTM)3.39B
Gross Profit (TTM)1.52B
EBITDA-1.93B
Profit Margin-84.94%
Operating Margin-308.47%
Return on Equity-49.68%
Return on Assets-18.42%
Shares Outstanding16.38M
Shares Float3.80M
Beta1.36
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%